Comparison of the collagen haemostat Sangustop® versus a carrier-bound fibrin sealant during liver resection; An open, randomized, prospective, multicenter, trial

Christian Moench, Moritz Wente, Wolfgang Thasler, Peter Buechler, Thomas Kraus, Christoph Seiler, Daniel Seehofer, Hans-Joerg Mischinger & Wolf Otto Bechstein
Introduction: A new collagen haemostat is expected to be as effective and safe as an established. The aim of this trial was to confirm the non-inferiority of the collagen haemostat Sangustop® versus the carrier-bound fibrin sealant Tachosil® in liver resection. Material and methods: This[for full text, please go to the a.m. URL]